Stay updated on Durvalumab and Daratumumab in MM Clinical Trial

Sign up to get notified when there's something new on the Durvalumab and Daratumumab in MM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab and Daratumumab in MM Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page revision updates metadata to v3.4.2 and removes non-core topic entries (Multiple Myeloma, MedlinePlus Genetics). No core study content, such as trial design, eligibility criteria, interventions, or primary outcomes, was changed; to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T12:34:00.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.0 to v3.4.1; all other page content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T15:36:39.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Added a glossary toggle, new related topic links (Multiple Myeloma and MedlinePlus Genetics), and footer/version text updates (Revision: v3.4.0) with minor wording adjustments; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-29T07:01:07.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    Multiple myeloma is no longer mentioned in the Study Details, and the related MedlinePlus Genetics topic is removed. This reduces disease-specific context and access to related genetics resources for readers.
    Difference
    0.1%
    Check dated 2026-01-22T05:00:37.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    Related topics now include MedlinePlus Genetics and the keyword 'Multiple myeloma' added to the page; the site revision has been updated from v3.3.3 to v3.3.4.
    Difference
    0.1%
    Check dated 2026-01-15T02:52:58.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    Added a Locations section listing trial sites by US state and Canadian province (CA, CO, GA, IL, MD, MA, MO, NJ, PA, TN, WA; NB, ON, QC) and adjusted or removed prior location blocks. This clarifies where the study is conducted and where participants may enroll.
    Difference
    1%
    Check dated 2025-12-23T14:26:53.000Z thumbnail image

Stay in the know with updates to Durvalumab and Daratumumab in MM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab and Daratumumab in MM Clinical Trial page.